Ginkgo Bioworks Holdings Inc vs Gartner Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $591.19M), while Gartner Inc trades at $132.89 (market cap $9.46B). The key difference: Gartner Inc is far larger — about 16× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Gartner Inc nearer its low. Which is the better fit depends on your goals.
| DNA | IT | |
|---|---|---|
Market Cap | $591.19M | $9.46B |
Sector | Health | Technology |
52-Week High | $16.14 | $363.58 |
52-Week Low | $5.48 | $125.68 |
Enterprise Value | $628.43M | $11.05B |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →